Our customers and partners continue to expand on an increasing body
of
literature, discussing studies that have been carried out with the help
of
Invitron's diagnostic test kits.
Sample Publications
Below are sample publications of research carried out with the help of Invitron diagnostic test kits:
Insulin assays
Manley SE, Stratton IM, Clark PM, Luzio SD. Clin Chem. 2007
May;53(5):922-32.Comparison of 11 Human Insulin Assays: Implications for Clinical
Investigation and Research.
> View
abstract
Cozma LS, Luzio SD, Dunseath GJ, Langendorg KW, Pieber T,
Owens DR. Diabetes Care 2002; 25:
1271-1276.
Comparison of the effects of three insulinotropic drugs on
plasma insulin levels after a standard meal.
> View abstract
Pfützner A, Langenfeld M,
Kunt T, Löbig M, Forst T.
Clin Lab.
2003;49(11-12):571-6. Evaluation of human resistin assays with serum from patients with
type 2 diabetes and different degrees of insulin resistance.
> View abstract
Cozma LS, Luzio SD, Dunseath GJ,
Underwood PM, Owens DR.
β-cell response during a test meal: a comparative study of incremental
doses of repaglinide in type 2 diabetic patients. Diabetes Care 2005;
28: 1001-1007.
>
View
abstract
Butter NL, Hattersley AT, Clark
PM. Clin Chim Acta. 2001; 310: 141-150.
Development of a bloodspot
assay for insulin.
> View abstract
Shields BM, Knight B, Shakespeare
L, Babrah J, Powell RJ,
Clark PM, Hattersley AT. Determinants of insulin concentrations in
healthy 1-week-old babies in the community: Applications of a bloodspot
assay. Early Human Development 2006; 82: 143-148.
>
View
abstract
Proinsulin assays
Luzio SD, Lucas I, Owens DR.
Importance of validation of
immunoassays for intact proinsulin. Clin Chem Lab Med. 2001; 39(7):
631-633.
> View abstract
Pfützner A, Kunt T,
Langenfeld M, Löbig M, Knesovic
M, Forst T. Clinical and laboratory evaluation of specific
chemiluminescence assays for intact and total proinsulin. Clin Chem Lab
Med. 2003;41(9):1234-8.
> View abstract
Pfützner A, Kunt T, Hohberg
C, Mondok A, Pahler S,
Konrad T, Lübben G, Forst T. Fasting intact proinsulin is a highly
specific predictor of insulin resistance in type 2 diabetes. Diabetes
Care. 2004;27(3):682-7.
>
View
abstract
Pfützner A, Kann PH,
Pfützner AH, Kunt T, Larbig M,
Weber MM, Forst T. Intact and total proinsulin: new aspects for
diagnosis and treatment of type 2 diabetes mellitus and insulin
resistance. Clin Lab. 2004;50(9-10):567-73.
>
View
abstract
Langenfeld MR, Forst T, Standl E, Strotmann H-J, Lübben
G, Pahler S, Kann P, Pfützner A. IRIS II Study: Sensitivity and
Specificity of Intact Proinsulin, Adiponectin, and the
Proinsulin/Adiponectin Ratio as Markers for Insulin Resistance.
Diabetes Technol Ther. 2004;6(6):836-43.
>
View
abstract
Pfützner A, Standl E,
Hohberg C, Strotmann HJ,
Lübben G, Langenfeld MR, Schulze J, Forst T. IRIS II Study: Intact
proinsulin is confirmed as a highly specific indicator for insulin
resistance in a large cross-sectional study design. Diabetes Technol
Ther. 2005; 7(3): 478-486.
>
View
abstract
C-Peptide assays
Luzio SD, Dunseath G, Lockett A, Broke-Smith TP, New RR, Owens DR.
The glucose lowering effect of an oral insulin (Capsulin) during an
isoglycaemic clamp study in persons with type 2 diabetes.
>
View
abstract